NCT02396368 A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer Status WITHDRAWN Phase PHASE1
NCT02391480 A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT02391051 Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial Status RECRUITING Phase PHASE2
NCT02388308 Evaluation of Clarity Ultrasound Guidance for Prostate Therapy Status COMPLETED Phase N/A
NCT02388126 Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies Status COMPLETED Phase NA
NCT02382094 Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy Status COMPLETED Phase PHASE3
NCT02381015 Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a Status COMPLETED Phase NA
NCT02380274 Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) Status COMPLETED Phase N/A
NCT02379559 Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men Status COMPLETED Phase NA
NCT02379260 Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer Status COMPLETED Phase NA
NCT02376296 Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients Status COMPLETED Phase N/A
NCT02375776 Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention Status COMPLETED Phase NA
NCT02375035 Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer Status UNKNOWN Phase N/A
NCT02366494 Micro RNAs to Predict Response to Androgen Deprivation Therapy Status COMPLETED Phase N/A
NCT02362464 Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 Status COMPLETED Phase PHASE2
NCT02362451 Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer Status TERMINATED Phase PHASE2